Head and neck cancers
- FDA Approves Lymphoseek for Determining the Extent of Squamous Cell Carcinoma of the Oral Cavity
- No Prognostic Effect of HPV on the Outcome of Primary Radiotherapy in Advanced Non-Oropharyngeal Cancers
- Smriti Nayan
- Combining HPV Status and Intratumour Heterogeneity for Predicting Outcome in Head and Neck Squamous Cell Carcinoma Patients
- ESMO @ ECC 2013: No Benefit Seen from Adding Zalutumumab to Radiotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
- ECC 2013 Press Release: Hyperfractionated Radiotherapy Improves Survival in Head and Neck Cancer Patients
- A Comprehensive Genomic Mutation Profiling Analysis of Adenoid Cystic Carcinoma
- ESMO Guides for Patients: Disclaimer and declaration of interest
- Multiple Tyrosine Kinases Targeting in Thyroid Cancer – a Novel Treatment Strategy for an Increasing in Frequency Tumour
- Nasopharyngeal Cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines
- Joint ESMO-ESTRO symposium tackles brain metastases
- Case for including patients with brain metastases in clinical trials
- Treatment advances in head and neck cancer
- Let’s get personal about cancer
- COG study: Addressing the need for second-line treatments in oesophageal cancer
- ESMO Clinical Practice Guidelines: Head and Neck Cancers
- Nasopharyngeal Carcinoma – a rare but potentially curable disease
- Gene expression profiling predicts the development of oral cancer
- Squamous Cell Carcinoma of the Head and Neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines